Evidence map›Paper›PMID 36995213›Full record

ArticleeLife2023

Model-based whole-brain perturbational landscape of neurodegenerative diseases.

Yonatan Sanz Perl, Sol Fittipaldi, Cecilia Gonzalez Campo, Sebastián Moguilner, Josephine Cruzat, Matias E Fraile-Vazquez, Rubén Herzog, Morten L Kringelbach, Gustavo Deco, Pavel Prado and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Linearizing and Forecasting: A Reservoir Computing Route to Digital Twins of the Brain.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. The landscape of dementia research, diagnosis, treatment, and care in Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  5. Article
  6. A complex network perspective on brain disease.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  7. Article
  8. A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Excitation-inhibition homeostasis in Alzheimer's disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Creative experiences and brain clocks.Nature communications · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 10 countries.

Yonatan Sanz PerlDepartment of Physics, University of Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0002-1270-5564
Sol FittipaldiNational Scientific and Technical Research Council (CONICET), CABA, Buenos Aires, Argentina.
Cecilia Gonzalez CampoNational Scientific and Technical Research Council (CONICET), CABA, Buenos Aires, Argentina.
Sebastián MoguilnerGlobal Brain Health Institute, University of California, San Francisco, San Francisco, United States.
Josephine CruzatCenter for Brain and Cognition, Computational Neuroscience Group, Universitat Pompeu Fabra, Barcelona, Spain.
Matias E Fraile-VazquezCognitive Neuroscience Center (CNC), Universidad de San Andrés, Buenos Aires, Argentina.
Rubén HerzogLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Morten L KringelbachDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Gustavo DecoCenter for Brain and Cognition, Computational Neuroscience Group, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-8995-7583
Pavel PradoLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0002-1324-6400
Agustin IbanezNational Scientific and Technical Research Council (CONICET), CABA, Buenos Aires, Argentina.ORCID 0000-0001-6758-5101
Enzo TagliazucchiDepartment of Physics, University of Buenos Aires, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARAdolfo Ibáñez University · CLAarhus University · DKInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat Pompeu Fabra · ESUniversity of California, San Francisco · USUniversity of San Andrés · AR

Funding

US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
NIA NIH HHS R01 AG057234
6 · The paper itself

Abstract

The treatment of neurodegenerative diseases is hindered by lack of interventions capable of steering multimodal whole-brain dynamics towards patterns indicative of preserved brain health. To address this problem, we combined deep learning with a model capable of reproducing whole-brain functional connectivity in patients diagnosed with Alzheimer's disease (AD) and behavioral variant frontotemporal dementia (bvFTD). These models included disease-specific atrophy maps as priors to modulate local parameters, revealing increased stability of hippocampal and insular dynamics as signatures of brain atrophy in AD and bvFTD, respectively. Using variational autoencoders, we visualized different pathologies and their severity as the evolution of trajectories in a low-dimensional latent space. Finally, we perturbed the model to reveal key AD- and bvFTD-specific regions to induce transitions from pathological to healthy brain states. Overall, we obtained novel insights on disease progression and control by means of external stimulation, while identifying dynamical mechanisms that underlie functional alterations in neurodegeneration.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaNeurodegenerative DiseasesAtrophyBrainHumansMagnetic Resonance Imagingdeep learningfMRIhumanneurodegenerationneurosciencewhole-brain computational modelling

Identifiers

PMID36995213
PMCPMC10063230
OpenAlexW4361271275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.